Kaila Petronila Medina Alarcón

Under Graduate in Pharmacy-Biochemistry-Industrial at the Federal University of Paraíba (UFPB 2008) Brazil and by the university Cayetano Heredia (2010) -Perú, Master (2014) and PhD (2018) in Biosciences and Biotechnology applied to Pharmacy by Universidade Estadual Paulista Júlio de Mesquita Filho-Araraquara, Brazil. Split doctoral program in the second semester of 2017 at Macquarie University in Sydney-Australia, in the Faculty of Medicine and Medical Sciences. Experience in Microbiology and Pharmaceutical nanotechnology area, research development mainly in: mixed microbial biofilms of biohazard safety three, parasite-host interaction, antifungal, antibacterial and antimycobacterial activity (working with microorganisms as Paracoccidioides spp., Histoplasma capsulatum, Candida spp., Mycobacterium tuberculosis, Staphylococcus aureus, S. epidermidis and Pseudomona aeruginosa), determination of cytotoxicity in cell lines, determination of cytotoxicity in alternative model at Galleria mellonella in the development of nanostructured lipid systems. microemulsions and nanoemulsions, characterization of these nanoparticles. Other experience: Quality control physicochemical and stability at the Laboratory Química Suiza Ltda. group Novartis (2010 Peru). (Source: Lattes Curriculum)